TOIThe Oncology Institute, Inc.
4.595USD+0.11%Mkt Cap: 459.92M USDP/E: Last update: 2026-05-26

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The compa…

Indicators:|

Key Statistics

Company
Market Cap459.92M USD
Enterprise Value521.56M USD
Revenue (TTM)545.76M USD
Gross Profit76.44M USD
Net Income (TTM)-60.61M USD
Revenue/Share5.537 USD
Last Price4.595 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees641
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-27.94
PEG
EV/EBITDA-20.13
EV/Revenue0.96
P/S0.82
P/B-28.11
EPS (TTM)-0.35
EPS (Forward)-0.16
52W Range
2.01590% of range4.880
52W High4.880 USD
52W Low2.015 USD
Profitability
Gross Margin15.20%
Oper. Margin-4.42%
EBITDA Margin-4.75%
Profit Margin-12.06%
ROE385.53%
ROA-36.81%
Growth
Revenue Growth41.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-24.59M USD
CapEx (TTM)3.20M USD
FCF Margin-2.81%
FCF Yield-3.33%
Net Debt74.63M USD
Net Debt/EBITDA-2.88
Balance Sheet
Debt/Equity-6.60
Current Ratio1.47
Quick Ratio1.13
Book Value/Sh-0.1590 USD
Cash/Share0.3030 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)7.000 USD
Target Range5.000 USD8.000 USD
# Analysts4
Ownership
Shares Out.99.98M
Float87.47M
Insiders18.18%
Institutions46.09%
Short Interest
Short Ratio5.5d
Short % Float8.36%
Short % Out.7.33%
Shares Short7.33M
Short (prev mo.)8.30M
Technical
SMA 503.512 (+30.8%)
SMA 2003.466 (+32.6%)
Beta0.36
S&P 52W Chg28.31%
Avg Vol (30d)1.61M
Avg Vol (10d)2.14M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)